Cargando…
Remdesivir in moderate to severe COVID-19: A matter of time?
Autores principales: | Bonazzetti, Cecilia, Giacomelli, Andrea, Pavia, Martina, Fusetti, Chiara, Gerbi, Martina, Petri, Francesco, Poloni, Andrea, Oreni, Letizia, Ridolfo, Anna Lisa, Antinori, Spinello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172330/ https://www.ncbi.nlm.nih.gov/pubmed/34089865 http://dx.doi.org/10.1016/j.phrs.2021.105711 |
Ejemplares similares
-
Estimating the effectiveness of remdesivir on risk of COVID-19 mortality: The role of observational data
por: Giacomelli, Andrea, et al.
Publicado: (2022) -
Mortality rates among COVID-19 patients hospitalised during the first three waves of the epidemic in Milan, Italy: A prospective observational study
por: Giacomelli, Andrea, et al.
Publicado: (2022) -
Trend in the proportion of subjects with SARS-CoV-2 infection without COVID-19 specific symptoms among patients admitted to a COVID-19 referral hospital
por: Giacomelli, Andrea, et al.
Publicado: (2023) -
Evolution of the SARS-CoV-2 epidemic: From genomic surveillance to new health needs
por: Giacomelli, Andrea, et al.
Publicado: (2023) -
Low influenza vaccination coverage among hospitalized COVID-19 patients in Milan: A gap to be urgently filled
por: Ridolfo, Anna Lisa, et al.
Publicado: (2021)